The CMS has assigned a permanent J-code for Omidria, Omeros announced in a press release.
Omidria (phenylephrine 1% and ketorolac 0.3% intraocular solution) is used during cataract surgery to prevent miosis and reduce postoperative pain.
The reimbursement code J1097 will become effective Oct. 1.
“Having a permanent J-code will simplify billing and payment, further enhancing patient access to Omidria,” Gregory A. Demopulos, MD, chairman and CEO of Omeros, said in the release. “With the expanding body of evidence demonstrating the clinical benefits of Omidria — from
Uncategorized